Filed: 11/14/2023ACC: 0001420506-23-002207
📋 What this filing means
IKARIAN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 107 equity positions with a total reported market value of $831.35M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
107
Positions
$831.35M
Total AUM (reported)
36.67M
Total Shares
Allocation by class
COM$606.41M72.9%
TR UNIT$64.12M7.7%
UNIT SER 1$42.99M5.2%
COM NEW$40.12M4.8%
S&P BIOTECH$36.51M4.4%
SPONSORED ADS$13.03M1.6%
NAMEN AKT$10.82M1.3%
Portfolio Concentration
Top 3$194.81M23.4%
4–10$246.75M29.7%
11–25$205.62M24.7%
Rest$184.17M22.2%
Top 3 weight
23.4%
Top 10 weight
53.1%
Voting Authority Distribution
Total shares with voting rights: 36.67M
Sole
Full voting authority
36.67M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole107
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings107
Rows:
SAREPTA THERAPEUTICS INC
SOLEShares5.80K
TypeSH
Market value$70.26M
8.45%
Sole
5.80K
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares1.50K
TypeSH
Market value$64.12M
7.71%
Sole
1.50K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares310.56K
TypeSH
Market value$60.43M
7.27%
Sole
310.56K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares801.52K
TypeSH
Market value$49.15M
5.91%
Sole
801.52K
Shared
0.00
None
0.00
INVESCO QQQ TR
SOLEShares1.20K
TypeSH
Market value$42.99M
5.17%
Sole
1.20K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares5K
TypeSH
Market value$36.51M
4.39%
Sole
5K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares205.04K
TypeSH
Market value$35.60M
4.28%
Sole
205.04K
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares2.92M
TypeSH
Market value$31.07M
3.74%
Sole
2.92M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares280.95K
TypeSH
Market value$26.20M
3.15%
Sole
280.95K
Shared
0.00
None
0.00
MODERNA INC
SOLEShares2.44K
TypeSH
Market value$25.23M
3.04%
Sole
2.44K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares476.18K
TypeSH
Market value$20.53M
2.47%
Sole
476.18K
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares1.32K
TypeSH
Market value$19.75M
2.38%
Sole
1.32K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares656.23K
TypeSH
Market value$16.49M
1.98%
Sole
656.23K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares536.72K
TypeSH
Market value$15.84M
1.91%
Sole
536.72K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares144.58K
TypeSH
Market value$15.21M
1.83%
Sole
144.58K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares14K
TypeSH
Market value$14.58M
1.75%
Sole
14K
Shared
0.00
None
0.00
NOVAVAX INC
SOLEShares19.26K
TypeSH
Market value$13.95M
1.68%
Sole
19.26K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares7.76K
TypeSH
Market value$13.28M
1.60%
Sole
7.76K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares4.07K
TypeSH
Market value$11.99M
1.44%
Sole
4.07K
Shared
0.00
None
0.00
IMMUNOGEN INC
SOLEShares393.73K
TypeSH
Market value$11.85M
1.43%
Sole
393.73K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares258.88K
TypeSH
Market value$11.76M
1.41%
Sole
258.88K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares32.62K
TypeSH
Market value$10.82M
1.30%
Sole
32.62K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares2.78K
TypeSH
Market value$10.56M
1.27%
Sole
2.78K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares845.00
TypeSH
Market value$9.80M
1.18%
Sole
845.00
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares518.52K
TypeSH
Market value$9.21M
1.11%
Sole
518.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SAREPTA THERAPEUTICS INCSOLE | COM | 5.80K | SH | $70.26M 8.45% | 5.80K | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 1.50K | SH | $64.12M 7.71% | 1.50K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 310.56K | SH | $60.43M 7.27% | 310.56K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 801.52K | SH | $49.15M 5.91% | 801.52K | 0.00 | 0.00 |
INVESCO QQQ TRSOLE | UNIT SER 1 | 1.20K | SH | $42.99M 5.17% | 1.20K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 5K | SH | $36.51M 4.39% | 5K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 205.04K | SH | $35.60M 4.28% | 205.04K | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 2.92M | SH | $31.07M 3.74% | 2.92M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 280.95K | SH | $26.20M 3.15% | 280.95K | 0.00 | 0.00 |
MODERNA INCSOLE | COM | 2.44K | SH | $25.23M 3.04% | 2.44K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 476.18K | SH | $20.53M 2.47% | 476.18K | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 1.32K | SH | $19.75M 2.38% | 1.32K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 656.23K | SH | $16.49M 1.98% | 656.23K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 536.72K | SH | $15.84M 1.91% | 536.72K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 144.58K | SH | $15.21M 1.83% | 144.58K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 14K | SH | $14.58M 1.75% | 14K | 0.00 | 0.00 |
NOVAVAX INCSOLE | COM NEW | 19.26K | SH | $13.95M 1.68% | 19.26K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 7.76K | SH | $13.28M 1.60% | 7.76K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 4.07K | SH | $11.99M 1.44% | 4.07K | 0.00 | 0.00 |
IMMUNOGEN INCSOLE | COM | 393.73K | SH | $11.85M 1.43% | 393.73K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 258.88K | SH | $11.76M 1.41% | 258.88K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 32.62K | SH | $10.82M 1.30% | 32.62K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 2.78K | SH | $10.56M 1.27% | 2.78K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 845.00 | SH | $9.80M 1.18% | 845.00 | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 518.52K | SH | $9.21M 1.11% | 518.52K | 0.00 | 0.00 |
Page 1 of 5
…